Hydroxyprogesterone caproate

• Description:

  Hydroxyprogesterone caproate is a synthetic progestin, a steroid.

• Product Name Alternative:

  17α-Hydroxyprogesterone hexanoate; 17α-Hydroxyprogesterone caproate

• UNSPSC:

  12352211

• Hazard Statement:

  H360

• Target:

  Progesterone Receptor

• Type:

  Reference compound

• Related Pathways:

  Vitamin D Related/Nuclear Receptor

• Field of Research:

  Others

• Assay Protocol:

  https://www.medchemexpress.com/Hydroxyprogesterone-caproate.html

• Purity:

  99.29

• Solubility:

  DMSO : 25 mg/mL (ultrasonic) |H2O : < 0.1 mg/mL

• Smiles:

  CC([C@@]1(OC(CCCCC)=O)CC[C@@]2([H])[C@]3([H])CCC4=CC(CC[C@]4(C)[C@@]3([H])CC[C@]12C)=O)=O

• Molecular Formula:

  C27H40O4

• Molecular Weight:

  428.60

• Precautions:

  H360

• References & Citations:

  [1]Armstrong J. Unintended consequences--the cost of preventing preterm births after FDA approval of a branded version of 17OHP. N Engl J Med. 2011 May 5;364 (18) :1689-91.|[2]Hauth JC, et al. The effect of 17 alpha-hydroxyprogesterone caproate on pregnancy outcome in an active-duty military population. Am J Obstet Gynecol. 1983 May 15;146 (2) :187-90.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category:

  Reference compound1

• Clinical Information:

  Launched

• CAS Number:

  [630-56-8]